Skip to main content

Business

By Jessica Hagen | 03:54 pm | November 05, 2024
The company reported a 77% YOY increase in revenue in Q3 2024 and plans to release a generic version of Novo Nordisk's GLP-1 drug on its platform in 2025.
By Anthony Vecchione | 02:23 pm | November 05, 2024
The acquisition includes Jack's Canadian clinical assets, the authority to operate 16 medical clinics across 13 Canadian cities and the rights to operate clinics in Walmart stores in Canada.  
By Jessica Hagen | 12:00 pm | November 05, 2024
The company offers a marketplace for individuals seeking addiction and mental health treatment. It will use the funds to scale its workforce and expand its reach.
By Jessica Hagen | 12:59 pm | November 04, 2024
Last week, the wearables company announced it opened an investigation into apparent manipulation in trading its common shares following a 1-for-15 reverse stock split.
By Jessica Hagen | 06:20 pm | October 31, 2024
The acquisition of data company Sparta Science will allow Oura to expand its data analytics capabilities and its B2B offerings.
By Jessica Hagen | 02:30 pm | October 31, 2024
The investigation follows shareholder approval of a 1-for-15 reverse stock that took effect earlier this week.
By Jessica Hagen | 10:45 am | October 30, 2024
Vineeta Agarwala, general partner at Andreessen Horowitz (a16z) Bio + Health, sat down with MobiHealthNews to discuss knownwell's expansion into Texas.
By Jessica Hagen | 06:40 pm | October 25, 2024
The employer-focused hybrid care provider will use the funds to scale its operations and expand access to its preventative care model. 
By Jessica Hagen | 02:18 pm | October 25, 2024
The company will use the funds to scale its operations and further develop its technology as it aims to establish gait monitoring as a mainstream tool.
By Anthony Vecchione | 07:25 pm | October 24, 2024
The company's Synapsis AI platform automates complex data readings, which allows for more efficient and optimal clinical research.